Nexgel (NXGLW) Income from Non-Controlling Interests (2023 - 2025)
Nexgel's (NXGLW) quarterly Income from Non-Controlling Interests came in at $42000.0 in Q4 2025, up 61.54% YoY from $26000.0 in Q4 2024, and up 600.0% on a QoQ basis from $6000.0 in Q3 2025.
Nexgel (NXGLW) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends
Nexgel (NXGLW) has 3 years of Income from Non-Controlling Interests data on file, last reported at $42000.0 in Q4 2025.
- Quarterly Income from Non-Controlling Interests rose 61.54% year-over-year to $42000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $107000.0 (up 159.12% YoY) and the FY2025 annual result came in at $107000.0, up 158.79% from the prior year.
- Income from Non-Controlling Interests advanced to $42000.0 in Q4 2025, from $6000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $53000.0 in Q2 2023 to a low of -$94000.0 in Q2 2024.
- A 3-year average of -$8750.0 and a median of $6500.0 in 2023 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2024 — Income from Non-Controlling Interests plunged 2950.0% — and 2025, when it jumped 165.38%.
- Tracing NXGLW's Income from Non-Controlling Interests over 3 years: stood at -$89000.0 in 2023, then surged by 129.21% to $26000.0 in 2024, then surged by 61.54% to $42000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $42000.0 (Q4 2025), $6000.0 (Q3 2025), and $25000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 29,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | -61,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | -52,000.00 |
| Dec 31, 2023 | -89,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 7,000.00 |